On Tuesday, Goldman Sachs reaffirmed its Buy rating on shares of insurance brokerage firm Brown & Brown, Inc. (NYSE:BRO), maintaining a price target of $115.00. The firm's third-quarter 2024 adjusted earnings per share (EPS) of $0.93 surpassed the Visible Alpha Consensus and Goldman Sachs' own estimates of $0.85 and $0.88, respectively. The outperformance was attributed to stronger-than-anticipated organic growth and adjusted EBITDAC margin.
Brown & Brown's organic growth for the quarter was reported at 9.5%, which is significantly higher than the consensus of 7.6% and Goldman Sachs' estimate of 8.2%. This growth was primarily fueled by a notable 22.8% organic increase in the Programs segment, which was more than double the Visible Alpha Consensus projection of 11.5%.
The adjusted EBITDAC margin also exceeded expectations, coming in at 34.9% compared to the consensus and Goldman Sachs' prediction of 34.3% and 34.9%, respectively.
Despite these strong results, the Retail segment experienced a year-on-year contraction of 190 basis points in margins, influenced by one-time adjustments to incentive commissions.
However, the Programs and Wholesale segments contributed positively to the margin beat, with Programs outperforming by 370 basis points relative to street estimates, and Wholesale by 130 basis points. Moreover, better than expected investment income also played a role in the favorable margin results.
Looking ahead, Brown & Brown is expected to benefit from over $30 million in flood claim revenues related to Hurricane Helene, as indicated by disclosures in the company's 10-Q filing. This is based on an estimated 1.5% claim processing fee from approximately $2 billion in losses and loss adjustment expenses. Furthermore, additional flood claim revenues are anticipated from Hurricane Milton, which occurred in October.
In the face of moderating rates, Brown & Brown anticipates consistent pricing changes in the fourth quarter and is positioning for a strong end to the year. The detailed results, especially once the impacts of the Retail segment's one-time adjustments are clarified, are expected to be received positively by investors.
In other recent news, insurance brokerage firm Brown & Brown has seen several significant developments. The company reported a 12.5% increase in second-quarter revenue, reaching nearly $1.2 billion, and a 17.7% rise in adjusted earnings per share to $0.93. These financial improvements were bolstered by the successful completion of 10 strategic acquisitions, contributing approximately $13 million in annual revenues.
Brown & Brown has also announced a 15% increase in its regular quarterly cash dividend, marking the company's 31st consecutive annual dividend rise. Furthermore, the firm has expanded its leadership team with the appointments of Mike Neal and Mark Abate, and the addition of industry veteran Stephen P. Hearn to its board of directors.
In terms of acquisitions, Brown & Brown recently acquired the assets of The Canopy Group, a move that strengthens its presence in the personal and small business insurance sectors. On the analyst front, Truist Securities raised the price target for Brown & Brown to $116, maintaining a Buy rating.
Barclays initiated coverage of the company with an Equalweight rating, indicating a balanced outlook, while RBC Capital Markets maintained an Outperform rating. These are all recent developments and should be considered while making investment decisions.
InvestingPro Insights
Brown & Brown's strong performance, as highlighted in Goldman Sachs' reaffirmation of its Buy rating, is further supported by data from InvestingPro. The company's revenue growth of 12.21% over the last twelve months aligns with the impressive organic growth reported in the article. This growth is complemented by a robust EBITDA growth of 15.55% over the same period, underscoring the company's operational efficiency.
InvestingPro Tips reveal that Brown & Brown has raised its dividend for 32 consecutive years, demonstrating a commitment to shareholder returns that may appeal to long-term investors. This is particularly noteworthy given the company's strong financial performance and growth trajectory.
The company's P/E ratio of 29.5 and Price to Book ratio of 4.89 suggest that the stock is trading at a premium, which could be justified by its consistent growth and market position. However, with a PEG ratio of 0.88, the stock may still be attractively valued relative to its growth prospects.
For investors seeking more comprehensive analysis, InvestingPro offers an additional 8 tips for Brown & Brown, providing deeper insights into the company's financial health and market position.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.